124 related articles for article (PubMed ID: 35942343)
1. Protocol for generation of human peptide-specific primary CD8
Grant EJ; Gras S
STAR Protoc; 2022 Sep; 3(3):101590. PubMed ID: 35942343
[TBL] [Abstract][Full Text] [Related]
2. Screening self-peptides for recognition by mouse alloreactive CD8
Son ET; Paul-Heng M; Leong M; Wang C; Hill AE; Denkova M; Purcell AW; Mifsud NA; Sharland AF
STAR Protoc; 2023 Mar; 4(1):101943. PubMed ID: 36525346
[TBL] [Abstract][Full Text] [Related]
3. Production and purification of infectious diseases-associated tetramer for staining of CD8
Ye J; Lei W; Xiao C; Su X; Gao J; Li X; Li W; Wang P; Jiang Z; Chen G
STAR Protoc; 2022 Mar; 3(1):101206. PubMed ID: 35284834
[TBL] [Abstract][Full Text] [Related]
4. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
Walker EB; Haley D; Miller W; Floyd K; Wisner KP; Sanjuan N; Maecker H; Romero P; Hu HM; Alvord WG; Smith JW; Fox BA; Urba WJ
Clin Cancer Res; 2004 Jan; 10(2):668-80. PubMed ID: 14760090
[TBL] [Abstract][Full Text] [Related]
5. Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potential.
Loo Yau H; De Carvalho DD
STAR Protoc; 2021 Jun; 2(2):100549. PubMed ID: 34095863
[TBL] [Abstract][Full Text] [Related]
6. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
Lukacher AE; Moser JM; Hadley A; Altman JD
J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the glycolytic potential of mouse costimulated effector CD8
Agliano F; Ménoret A; Vella AT
STAR Protoc; 2022 Jun; 3(2):101441. PubMed ID: 35677608
[TBL] [Abstract][Full Text] [Related]
8. The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.
Singh SK; Meyering M; Ramwadhdoebe TH; Stynenbosch LF; Redeker A; Kuppen PJ; Melief CJ; Welters MJ; van der Burg SH
Cancer Immunol Immunother; 2012 Nov; 61(11):1953-63. PubMed ID: 22491788
[TBL] [Abstract][Full Text] [Related]
9. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
10. Isolation of adoptively transferred CD8
Xiao L; Yi Q
STAR Protoc; 2023 Mar; 4(1):101945. PubMed ID: 36525345
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining.
Gonzalez-Nieto L; Domingues A; Ricciardi M; Gutman MJ; Maxwell HS; Pedreño-Lopez N; Bailey V; Magnani DM; Martins MA
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060314
[TBL] [Abstract][Full Text] [Related]
12. Protocol for real-time monitoring of CD8
Laforêts F; Donnadieu E; Balkwill F
STAR Protoc; 2024 Jun; 5(2):103102. PubMed ID: 38833373
[TBL] [Abstract][Full Text] [Related]
13. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses.
Belz GT; Xie W; Doherty PC
J Immunol; 2001 Apr; 166(7):4627-33. PubMed ID: 11254721
[TBL] [Abstract][Full Text] [Related]
14. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
Appel H; Kuon W; Kuhne M; Wu P; Kuhlmann S; Kollnberger S; Thiel A; Bowness P; Sieper J
Arthritis Res Ther; 2004; 6(6):R521-34. PubMed ID: 15535830
[TBL] [Abstract][Full Text] [Related]
15. Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
Pittet MJ; Speiser DE; Liénard D; Valmori D; Guillaume P; Dutoit V; Rimoldi D; Lejeune F; Cerottini JC; Romero P
Clin Cancer Res; 2001 Mar; 7(3 Suppl):796s-803s. PubMed ID: 11300475
[TBL] [Abstract][Full Text] [Related]
16. Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.
Miyai M; Eikawa S; Hosoi A; Iino T; Matsushita H; Isobe M; Uenaka A; Udono H; Nakajima J; Nakayama E; Kakimi K
PLoS One; 2015; 10(8):e0136086. PubMed ID: 26291626
[TBL] [Abstract][Full Text] [Related]
17. Detection of CD8
Wu J; Li G; Li D; Zhou J; Dong Z; Jiang P
STAR Protoc; 2021 Dec; 2(4):101022. PubMed ID: 34977671
[TBL] [Abstract][Full Text] [Related]
18. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
[TBL] [Abstract][Full Text] [Related]
19. Isolation of tumor-resident CD8
Corgnac S; Lecluse Y; Mami-Chouaib F
STAR Protoc; 2021 Mar; 2(1):100267. PubMed ID: 33490983
[TBL] [Abstract][Full Text] [Related]
20. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.
Drake DR; Ream RM; Lawrence CW; Braciale TJ
J Immunol; 2005 Aug; 175(3):1507-15. PubMed ID: 16034088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
